retatrutide in south africa Significantly Reduces Visceral Fat Clinical Trials Retatrutide: The New Triple-Agonist Weight

[DOI] [PMC free article] [PubMed] [Google Scholar] 17.Rahbek MT, Lund LC, Hallas J

However, when fatty acid delivery exceeds mitochondrial oxidative and redox-buffering capacity, increased electron transport pressure can elevate reactive oxygen species (ROS) production, promote endoplasmic reticulum stress, and increase susceptibility to lipid peroxidation [54, 61,62,63]

In humans, GLP-1 receptors are expressed in several tissues, including lung tissue

Heres what actually matters: The critical distinction: Retatrutide isnt just a little better. The most recent Phase 3 data (TRIUMPH-4 trial, December 2025) showed participants on the 12 mg dose lost an average of 28.7% of their body weight at 68 weeks

Research shows that patients who start GLP-1 therapy within 3 months of deciding to pursue it achieve 20% better outcomes than those who wait

Lundgren JR, Janus C, Jensen SBK, et al